Cephalalgia Reports retweeted
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Great news for researchers! The submission deadline has been extended — you now have until 📅 28 March 2026 to submit your original research papers for the Jes Olesen Awards in Basic Science and Clinical Science.
Cephalalgia is proud to honour outstanding early‑career researchers whose work drives innovation in headache medicine. Two awards — one in Basic Science and one in Clinical Science — will each grant €10,000 and an opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old
🔹 Submission type: Original research only
🔹 Limit: One submission per participant
📖 Full guidelines: journals.sagepub.com/page/ce…
Funded by Professor Jes Olesen through JO Health, these awards empower the next generation of headache researchers worldwide.
🌍 Don’t miss this chance to elevate your work, gain international visibility, and contribute to the future of headache science!
#JesOlesenAwards #HeadacheResearch #Cephalalgia #IHS #CallForPapers #ResearchOpportunity
Cephalalgia Reports retweeted
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Great news for researchers! The submission deadline has been extended — you now have until 📅 28 March 2026 to submit your original research papers for the Jes Olesen Awards in Basic Science and Clinical Science.
Cephalalgia is proud to honour outstanding early‑career researchers whose work drives innovation in headache medicine. Two awards — one in Basic Science and one in Clinical Science — will each grant €10,000 and an opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old
🔹 Submission type: Original research only
🔹 Limit: One submission per participant
📖 Full guidelines: journals.sagepub.com/page/ce…
Funded by Professor Jes Olesen through JO Health, these awards empower the next generation of headache researchers worldwide.
🌍 Don’t miss this chance to elevate your work, gain international visibility, and contribute to the future of headache science!
#JesOlesenAwards #HeadacheResearch #Cephalalgia #IHS #CallForPapers #ResearchOpportunity
Cephalalgia Reports retweeted
🎉 Milestone Reached!
We are delighted to announce that the International Headache Society’s Facebook page has grown to 15,000 followers!
Thank you to our global community for your continued support. We remain committed to sharing the latest news in headache medicine, updates on the activities of headache societies around the world, and cutting-edge research in this field.
#IHS #migraine #headache #15KFollowers
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official - Visual Snow (VS) is a recently recognized neurological condition presenting, continuous, tiny dots across the entire visual field, accompanying by nyctalopia, photophobia and palinopsia that persist for months.- journals.sagepub.com/doi/ful…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official @arne_may - Open Access for @JCephalalgia read the editorial - doi.org/10.1177/033310242211…
Cephalalgia Reports retweeted
New daily persistent headache was first documented in the medical literature in the 1980s. The leading trigger is a viral illness. Check the link in bio to read the paper at @JCephalalgia.
#cephalalgia #headache #neurology #brain #pain #headachemedicine
🔗https://teapaw.org/t.co/jRd9M91fkL
Cephalalgia Reports retweeted
It's good to see online webinars available in the IHS learning center again, remember this webinar about Intracranial Hypertension. Go visit our website!
#IHS_Learning_Centre #education #IHS_videos
🔗https://teapaw.org/t.co/cRmIKBCQEz
Cephalalgia Reports retweeted
No boundaries, no barriers to Science: So proud to see Cephalalgia entering a new era
doi.org/10.1177/033310242211…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official @arne_may - #Headache research without boundaries: Cephalalgia and Open Access - doi.org/10.1177/033310242211…
Cephalalgia Reports retweeted
.@ihs_official Reminder MTIS program online . mtis2022.org/programme/scien…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official @HenrikSchytz- #Headache patients have attempted several non-pharmacological treatments, but limited pharmacological treatment prior to their first visit at a tertiary headache center. -journals.sagepub.com/doi/ful…
Cephalalgia Reports retweeted
Infantile colic is common in infants but DYK there is a possible association between the development of migraine and colic? This study showed that over 70% of children with migraine had reported infantile colic suggesting a shared pathogenic mechanism common to both.
Cephalalgia Reports retweeted
Membership of the IHS gives access to the learning centre where you can access various resources published by IHS including previous quarterly webinars. Visit our website to find out more information.
#neurology #neuroscience #IHS #headache #migraine #meded
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official @langer_laura @DocMarkBayley @davidwlawrence1 - For most people, post-traumatic #headache onset is within 24 h of a concussion. New research from @Hull_EllisCC looks at ICHD diagnostic criteria for post traumatic headache - journals.sagepub.com/doi/ful…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official -This International Headache Society document may serve as guidance for developing clinic-based #headache registries - journals.sagepub.com/doi/ful…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official - This review is the first meta-analysis to exhibit significant improvements in acute medication intakes and disability with the HF-rTMS neuromodulation treatment at DLPFC among #migraine patients. - doi.org/10.1177/033310242210…
Cephalalgia Reports retweeted
Deadline: 12 May 2022!
The IHS Junior Research Grant aims to support innovative and impactful research, promote the career of young investigators in the field of headache, and increase the knowledge of headache disorders. ihs-headache.org/en/resource…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official -Lacosamide can be an effective option as intravenous treatment of pain in trigeminal neuralgia, with low proportion of adverse effects. - journals.sagepub.com/doi/ful…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official - Intravenous lacosamide and phenytoin can be effective and safe treatments for acute pain in trigeminal neuralgia -journals.sagepub.com/doi/ful…
Cephalalgia Reports retweeted
.@JCephalalgia @ihs_official @arne_may - Chronic facial pain that has no dental cause is probably underdiagnosed and definitely under treated - journals.sagepub.com/doi/ful…










